News
Faster Access Via Recognition Routes – Initiative By MHRA
The medicines and healthcare products regulatory agency has gone on to announce that the new global regulatory recognition routes for drugs will be established by making use of approvals from Singapore, Canada, Japan, the US, Australia, Switzerland, and, of...
News
Measuring Omnichannel Success in the Pharma Industry: Key Insights and Strategies
The pharma industry has witnessed a paradigm shift in marketing approaches with the rise of omnichannel strategies. To effectively evaluate the impact of these initiatives, measuring omnichannel success becomes crucial. This article explores the importance of measuring omnichannel performance...
Drug Research
EMA Recommendation Suggests How To Combat Medicine Shortages
The European Medicines Agency has published recommendations to tackle medicine shortages and their associated repercussions. These recommendations emphasize the importance of ensuring the availability of authorized medicines in the European Union. Key recommendations include promptly informing national authorities about...
IT & Data Management
Mixed Reactions From Scientists As AI Emerges Pharma Sector
Artificial Intelligence remains a hot topic in the pharma spectrum, and the current ChatGPT wave has begun many more conversations. As of now, there happens to be a bifurcation of attitudes, with some researchers pretty much excited when it...
IT & Data Management
The Rising Value of Machine Learning In Pharmaceuticals
Machine learning, when it comes to the pharma sector, had a value of almost $1.2 billion in 2021, and it is anticipated to touch $26.2 billion in another 10 years, with a CAGR of 37.9% right from 2022 to...
News
Biotech Firms In Switzerland Prepare For European Launch
Analysis shows Switzerland has become the chosen headquarters for 20 per cent of European biotech companies. Out of a total of 265 companies that have settled in Switzerland, 63 of them are in the biotech sector, making it the...
IT & Data Management
Overcoming Counterfeit Challenges With Blockchain In Pharma
Researchers from Sweden have identified the advantages of employing smart contracts on blockchain platforms within the pharmaceutical supply chain to combat counterfeit drugs. Despite the estimated value of the counterfeit market exceeding $200 billion and the numerous benefits it...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read















